Rubicon Research Limited (NSE:RUBICON)
India · Delayed Price · Currency is INR 821.30
+1.55 (0.19%)
At close: Apr 15, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 135.31 billion as of April 16, 2026.
Market Cap
135.31B
Enterprise Value
139.47B
Revenue
15.98B
Ranking
n/a
PE Ratio
63.01
Stock Price
821.30
Market Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 135.31B, an increase of 30.74%. That is a compound annual growth rate of 71.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 135.31B | 20.65% |
| Dec 31, 2025 | 112.15B | 8.37% |
| Oct 16, 2025 | 103.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 407.63B |
| J. B. Chemicals & Pharmaceuticals | 320.90B |
| AstraZeneca Pharma India | 214.18B |
| Granules India | 161.59B |
| Jubilant Pharmova | 143.45B |
| Caplin Point Laboratories | 128.17B |
| CORONA Remedies | 96.76B |
| Viyash Scientific | 91.70B |